Interaction of retinal pigmented epithelial cells and CD4 T cells Leads to T-cell anergy

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 10, 2007, Pages 4654-4663

  Gregerson, Dale S ^a   Heuss, Neal D ^a   Lew, Kathleen L ^a   McPherson, Scott W ^a   Ferrington, Deborah A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD69 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; B7 ANTIGEN; CYTOKINE; HLA ANTIGEN CLASS 2; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; OVALBUMIN; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL IMMORTALIZATION; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; MOUSE; NONHUMAN; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; ANTIGEN PRESENTATION; COCULTURE; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONAL ANERGY; COCULTURE TECHNIQUES; CYTOKINES; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; OVALBUMIN; PEPTIDE FRAGMENTS; PEPTIDES; PIGMENT EPITHELIUM OF EYE;

EID: 35748982436     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0286     Document Type: Article

References (54)

1. Young RW, Bok D. Participation of the retinal pigment epithelium in the rod outer segment renewal process. J Cell Biol. 1969;42:392-402.
2. Adamus G, Chan CC. Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int Rev Immunol. 2002;21:209-229.
3. Gery I, Egwuagu CE. Central tolerance mechanisms in control of susceptibility to autoimmune uveitic disease. Int Rev Immunol. 2002;21:89-100.
4. DeVoss J, Hou Y, Johannes K, et al. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med. 2006;203:2727-2735.
5. Fling SP, Donoso LA, Gregerson DS. In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen. J Immunol. 1991;147:483-489.
6. Avichezer D, Grajewski RS, Chan CC, et al. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J Exp Med. 2003;198:1665-1676.
7. Prasad SA, Fling SP, Gregerson DS. Differential APC requirements of self- and nonself-reactive T cells and T cell hybridomas specific for retinal S-antigen. J Autoimmun. 1997;10:1-9.
8. Gregerson DS, Dou C. Spontaneous induction of immunoregulation by an endogenous retinal antigen. Invest Ophthalmol Vis Sci. 2002;43:2984-2991.
9. Prendergast RA, Iliff CE, Coskuncan NM, et al. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 1998;39:754-762.
10. Gregerson DS, Kawashima H. APC derived from donor splenocytes support retinal autoimmune disease in allogeneic recipients. J Leukoc Biol. 2004;76:383-387.
11. Gregerson DS, Yang J. CD45-positive cells of the retina and their responsiveness to in vivo and in vitro treatment with IFN-gamma or anti-CD40. Invest Ophthalmol Vis Sci. 2003;44:3083-3093.
12. Xu H, Dawson R, Forrester JV, Liversidge J. Identification of novel dendritic cell populations in normal mouse retina. Invest Ophthalmol Vis Sci. 2007;48:1701-1710.
13. Matzinger P. The danger model: a renewed sense of self. Science. 2002;296:301-305.
14. Medzhitov R, Janeway CA Jr. How does the immune system distinguish self from nonself? Semin Immunol. 2000;12:185-188.
15. Hayashi RJ, Loh DY, Kanagawa O, Wang F. Differences between responses of naive and activated T cells to anergy induction. J Immunol. 1998;160:33-38.
16. Marelli-Berg FM, Weetman A, Frasca L, et al. Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells. J Immunol. 1997;159:5853-5861.
17. Chen TC, Cobbold SP, Fairchild PJ, Waldmann H. Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen. J Immunol. 2004;172:5900-5907.
18. Liversidge JM, Sewell HF, Forrester JV. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Clin Exp Immunol. 1988;73:489-494.
19. Liversidge J, Sewell HF, Thomson AW, Forrester JV. Lymphokine-induced MHC class II antigen expression on cultured retinal pigment epithelial cells and the influence of cyclosporin A. Immunology. 1988;63:313-317.
20. Percopo CM, Hooks JJ, Shinohara T, Caspi R, Detrick B. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J Immunol. 1990;145:4101-4107.
21. Elner VM, Scales W, Elner SG, Danforth J, Kunkel SL, Strieter RM. Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells. Exp Eye Res. 1992;54:361-368.
22. Holtkamp GM, Van Rossem M, de Vos AF, Willekens B, Peek R, Kijlstra A. Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells. Clin Exp Immunol. 1998;112:34-43.
23. Nagineni CN, Detrick B, Hooks JJ. Synergistic effects of gamma interferon on inflammatory mediators that induce interleukin-6 gene expression and secretion by human retinal pigment epithelial cells. Clin Diag Lab Immunol. 1994;1:569-577.
24. Crane IJ, Kuppner MC, McKillop-Smith S, Wallace CA, Forrester JV. Cytokine regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) production by human retinal pigment epithelial cells. Clin Exp Immunol. 1999;115:288-293.
25. Crane IJ, Kuppner MC, McKillop-Smith S, Knott RM, Forrester JV. Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol. 1998;184:37-44.
26. Sun D, Enzmann V, Lei S, Sun SL, Kaplan HJ, Shao H. Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels. J Neuroimmunol. 2003;144:1-8.
27. Kaestel CG, Lovato P, Odum N, Nissen MH, Ropke C. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro. Curr Eye Res. 2005;30:375-383.
28. Ishida K, Panjwani N, Cao Z, Streilein JW. Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul Immunol Inflamm. 2003;11:91-105.
29. Kaestel CG, Jorgensen A, Nielsen M, et al. Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Exp Eye Res. 2002;74:627-637.
30. Liversidge J, Grabowski P, Ralston S, Benjamin N, Forrester JV. Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells. Immunology. 1994;83:404-409.
31. Liversidge J, McKay D, Mullen G, Forrester JV. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 1993;149:315-330.
32. Jorgensen A, Wiencke AK, la Cour M, et al. Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci. 1998;39:1590-1599.
33. Gregerson DS, Sam TN, McPherson SW. The antigen-presenting activity of fresh, adult parenchymal microglia and perivascular cells from retina. J Immunol. 2004;172:6587-6597.
34. Gregerson DS, Lew KL, McPherson SW, Heuss ND, Ferrington DA. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing. Invest Ophthalmol Vis Sci. 2006;47:5385-5394.
35. Ferrington DA, Tran TN, Lew KL, Van Remmen H, Gregerson DS. Different death stimuli evoke apoptosis via multiple pathways in retinal pigment epithelial cells. Exp Eye Res. 2006;83:638-650.
36. Kappler JW, Skidmore B, White J, Marrack P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J Exp Med. 1981;153:1198-1214.
37. Dubreuil PC, Birnbaum DZ, Caillol DH, Lemonnier FA. Identification on I-Ak molecules of a functional site recognized by proliferating T-lymphocytes. Immunogenetics. 1982;16:407-424.
38. Gregerson DS, Xiao J. Failure of memory (CD44 high) CD4 T cells to recognize their target antigen in retina. J Neuroimmunol. 2001;120:34-41.
39. Gregerson DS, Torseth JW, McPherson SW, Roberts JP, Shinohara T, Zack DJ. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis. J Immunol. 1999;163:1073-1080.
40. Macian F, Im SH, Garcia-Cozar FJ, Rao A. T-cell anergy. Curr Opin Immunol. 2004;16:209-216.
41. Schwartz RH. T cell anergy. Annu Rev Immunol. 2003;21:305-334.
42. Liversidge J, Forrester JV. Antigen processing and presentation in the eye: a review. Curr Eye Res. 1992;11:49-58.
43. Magnus T, Schreiner B, Korn T, et al. Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci. 2005;25:2537-2546.
44. Racke MK, Scott DE, Quigley L, et al. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J Clin Invest. 1995;96:2195-2203.
45. Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000;192:1027-1034.
46. Subudhi SK, Alegre ML, Fu YX. The balance of immune responses: costimulation verse coinhibition. J Mol Med. 2005;83:193-202.
47. Willermain F, Caspers-Velu L, Baudson N, et al. Role and expression of CD40 on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:3485-3491.
48. Pinet V, Vergelll M, Martin R, Bakke O, Long EO. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature. 1995;375:603-606.
49. Pinet VM, Long EO. Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur J Immunol. 1998;28:799-804.
50. Moldenhauer G, Henne C, Karhausen J, Moller P. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments. Immunology. 1999;96:473-484.
51. Roche PA, Teletski CL, Stang E, Bakke O, Long EO. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci USA. 1993;90:8581-8585.
52. Slavin AJ, Soos JM, Stuve O, et al. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest. 2001;108:1133-1139.
53. Sekaly RP, Jacobson S, Richert JR, Tonnelle C, McFarland HF, Long EO. Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain. Proc Natl Acad Sci USA. 1988;85:1209-1212.
54. Stumptner-Cuvelette P, Benaroch P. Multiple roles of the invariant chain in MHC class II function. Biochim Biophys Acta. 2002;1542:1-13.